Viewing Study NCT01069705

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-05-18 @ 10:06 PM
Study NCT ID: NCT01069705
Status: COMPLETED
Last Update Posted: 2021-06-02
First Post: 2010-02-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Second Open Label Extension to Bridging Study CTBM100C2303
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Infections View
None Pseudomonas Aeruginosa View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tobramycin Inhalation Powder View
None Cystic fibrosis View
None Lung diseases View
None Anti-Bacterial Agents View
None Treatment of pulmonary infections with P. aeruginosa in cystic fibrosis … View